This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Baer, H. J. Articles by Colditz, G. A. Search for Related Content PubMed PubMed Citation Articles by Baer, H. J. Articles by Colditz, G. A.

Early Life Factors and Incidence of Proliferative Benign Breast Disease

¹ Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; Departments of ² Epidemiology, ³ Nutrition, and ⁴ Biostatistics, Harvard School of Public Health, Boston, Massachusetts; ⁵ Department of Pathology, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, Massachusetts; ⁶ Harvard Center for Cancer Prevention, Boston, Massachusetts; and ⁷ Cancer Genetics and Epidemiology Program, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia

Requests for reprints: Heather J. Baer, Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 181 Longwood Avenue, Boston, MA 02115. Phone: 617-525-2101; Fax: 617-525-2008. E-mail: hbaer{at}hsph.harvard.edu

Proliferative benign breast disease is a marker of increased breast cancer risk, yet little is known about its etiology. Most studies of benign breast disease have focused only on risk factors in adulthood, despite growing evidence that factors in early life influence breast cancer risk. We explored the relations of several early life factors with incidence of proliferative benign breast disease among 71,896 premenopausal women in the Nurses' Health Study II who recalled their body fatness at young ages, physical activity in adolescence, birthweight, and history of being breastfed. Between 1991 and 1997, 901 of these women were identified as having proliferative benign breast disease from a centralized pathology review. Relative risks (RR) and 95% confidence intervals (95% CI) were estimated from Cox proportional hazards models. Greater childhood body fatness (ages 5-10) was associated with decreased risk of proliferative benign breast disease; the multivariate RR (95% CI) for the most overweight compared with the most lean was 0.61 (0.44-0.86; P_trend < 0.0001) and remained significant after adjustment for current body mass index. Body mass index at age 18 was also inversely associated with incidence of proliferative benign breast disease, with a multivariate RR (95% CI) of 0.67 (0.52-0.88) for those who were 25 kg/m² compared with those who were <19 kg/m² (P_trend = 0.001). There were no clear associations for physical activity in adolescence, birthweight, or being breastfed. These results indicate that premenopausal women who were heavier at young ages have lower incidence of proliferative benign breast disease, consistent with previous findings for breast cancer. (Cancer Epidemiol Biomarkers Prev 2005;14(12):2889–97)

This article has been cited by other articles:

				S. S. Maruti, W. C. Willett, D. Feskanich, B. Rosner, and G. A. Colditz A Prospective Study of Age-Specific Physical Activity and Premenopausal Breast Cancer J Natl Cancer Inst, May 21, 2008; 100(10): 728 - 737. [Abstract] [Full Text] [PDF]

				J. W. Lampe, Y. Nishino, R. M. Ray, C. Wu, W. Li, M.-G. Lin, D. L. Gao, Y. Hu, J. Shannon, H. Stalsberg, et al. Plasma Isoflavones and Fibrocystic Breast Conditions and Breast Cancer Among Women in Shanghai, China Cancer Epidemiol. Biomarkers Prev., December 1, 2007; 16(12): 2579 - 2586. [Abstract] [Full Text] [PDF]

				R. M. Martin, J. M. P. Holly, G. Davey Smith, and D. Gunnell Associations of Adiposity from Childhood into Adulthood with Insulin Resistance and the Insulin-Like Growth Factor System: 65-Year Follow-Up of the Boyd Orr Cohort J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3287 - 3295. [Abstract] [Full Text] [PDF]